SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Jun-24 4:23 PM View: | Charles River Laboratories ... (CRL) | 31-May-24 | Grant | 1,967 | -- | -- | 15% 12.86K to 14.83K | |
29-May-24 5:48 PM View: | Charles River Laboratories ... (CRL) | 29-May-24 | Payment of Exercise | 190 | $214.51 | $40,756.90 | (1%) 13.14K to 12.95K | |
29-May-24 5:08 PM View: | Charles River Laboratories ... (CRL) | 28-May-24 | Payment of Exercise | 77 | $217.21 | $16,725.20 | (< 1%) 13.21K to 13.14K | |
29-May-24 5:08 PM View: | Charles River Laboratories ... (CRL) | 27-May-24 | Payment of Exercise | 122 | $217.21 | $26,499.60 | (< 1%) 13.34K to 13.21K | |
29-May-24 5:08 PM View: | Charles River Laboratories ... (CRL) | 26-May-24 | Payment of Exercise | 180 | $217.21 | $39,097.80 | (1%) 13.52K to 13.34K | |
01-Mar-24 5:37 PM View: | Charles River Laboratories ... (CRL) | 29-Feb-24 | Private Sale | 5,000 | $253.70 | $1,268,500.00 | (27%) 18.55K to 13.55K | |
31-Jan-24 5:26 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 2,997 | -- | -- | 18% 16.51K to 19.5K | |
31-Jan-24 5:26 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 953 | $220.28 | $209,927.00 | (5%) 19.5K to 18.55K | |
18-Dec-23 4:07 PM View: | Charles River Laboratories ... (CRL) | 14-Dec-23 | Option Exercise | 5,526 | $136.70 | $755,388.00 | 33% 16.51K to 22.03K | (3%) |
18-Dec-23 4:07 PM View: | Charles River Laboratories ... (CRL) | 14-Dec-23 | Planned Private Option Sale | 5,526 | $225.00 | $1,243,350.00 | (25%) 22.03K to 16.51K | |
31-May-23 1:18 PM View: | Charles River Laboratories ... (CRL) | 29-May-23 | Payment of Exercise | 190 | $194.12 | $36,882.80 | (1%) 16.7K to 16.51K | |
31-May-23 1:18 PM View: | Charles River Laboratories ... (CRL) | 28-May-23 | Payment of Exercise | 115 | $194.12 | $22,323.80 | (< 1%) 16.81K to 16.7K | |
31-May-23 1:18 PM View: | Charles River Laboratories ... (CRL) | 27-May-23 | Payment of Exercise | 170 | $194.12 | $33,000.40 | (1%) 16.98K to 16.81K | |
31-May-23 1:18 PM View: | Charles River Laboratories ... (CRL) | 26-May-23 | Grant | 2,009 | -- | -- | 13% 14.97K to 16.98K | |
22-Feb-23 5:17 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-23 | Payment of Exercise | 181 | $243.60 | $44,091.60 | (1%) 15.15K to 14.97K | |
22-Feb-23 5:17 PM View: | Charles River Laboratories ... (CRL) | 01-Feb-23 | Payment of Exercise | 343 | $248.21 | $85,136.00 | (2%) 15.5K to 15.15K | |
30-Jan-23 6:03 PM View: | Charles River Laboratories ... (CRL) | 31-Jan-23 | Payment of Exercise | 2,692 | $244.29 | $657,629.00 | (15%) 18.19K to 15.5K | |
30-Jan-23 6:03 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Grant | 7,229 | -- | -- | 66% 10.96K to 18.19K | |
31-May-22 6:08 PM View: | Charles River Laboratories ... (CRL) | 29-May-22 | Payment of Exercise | 190 | $244.41 | $46,437.90 | (2%) 11.15K to 10.96K | |
31-May-22 6:08 PM View: | Charles River Laboratories ... (CRL) | 28-May-22 | Payment of Exercise | 114 | $244.41 | $27,862.70 | (1%) 11.26K to 11.15K | |
31-May-22 6:08 PM View: | Charles River Laboratories ... (CRL) | 27-May-22 | Grant | 1,493 | -- | -- | 15% 9.77K to 11.26K | |
23-Feb-22 4:17 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-22 | Payment of Exercise | 180 | $293.61 | $52,849.80 | (2%) 9.95K to 9.77K | |
01-Feb-22 5:47 PM View: | Charles River Laboratories ... (CRL) | 01-Feb-22 | Payment of Exercise | 343 | $329.76 | $113,108.00 | (3%) 10.29K to 9.95K | |
01-Feb-22 5:47 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Grant | 6,302 | -- | -- | 99% 6.39K to 12.69K | |
01-Feb-22 5:47 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Payment of Exercise | 2,395 | $312.24 | $747,815.00 | (19%) 12.69K to 10.29K | |
17-Aug-21 3:01 PM View: | Charles River Laboratories ... (CRL) | 16-Aug-21 | Option Exercise | 6,917 | $145.34 | $1,005,330.00 | 108% 6.39K to 13.3K | (9%) |
17-Aug-21 3:01 PM View: | Charles River Laboratories ... (CRL) | 16-Aug-21 | Private Option Sale | 6,917 | $415.24 | $2,872,240.00 | (52%) 13.3K to 6.39K | |
01-Jun-21 5:56 PM View: | Charles River Laboratories ... (CRL) | 29-May-21 | Payment of Exercise | 127 | $337.99 | $42,924.70 | (2%) 6.51K to 6.39K | |
01-Jun-21 5:56 PM View: | Charles River Laboratories ... (CRL) | 28-May-21 | Grant | 1,006 | -- | -- | 18% 5.51K to 6.51K | |
24-Feb-21 10:33 AM View: | Charles River Laboratories ... (CRL) | 22-Feb-21 | Payment of Exercise | 121 | $289.55 | $35,035.50 | (2%) 5.63K to 5.51K | |
02-Feb-21 11:41 AM View: | Charles River Laboratories ... (CRL) | 01-Feb-21 | Payment of Exercise | 251 | $259.05 | $65,021.50 | (4%) 5.88K to 5.63K | |
22-May-18 4:47 PM View: | Itt Inc. (ITT) | 21-May-18 | Option Exercise | 7,640 | $41.52 | $317,213.00 | 50% 15.41K to 23.05K | |
22-May-18 4:47 PM View: | Itt Inc. (ITT) | 21-May-18 | Market Option Sale | 7,640 | $55.16 | $421,434.00 | (33%) 23.05K to 15.41K | (55%) |
28-Feb-18 7:42 PM View: | Itt Inc. (ITT) | 27-Feb-18 | Payment of Exercise | 3,237 | $52.99 | $171,529.00 | 27% 12.16K to 15.4K | 61% |
28-Feb-18 7:42 PM View: | Itt Inc. (ITT) | 26-Feb-18 | Grant | 6,758 | -- | -- | 57% 11.88K to 18.63K | |
24-Feb-17 9:07 PM View: | Itt Inc. (ITT) | 23-Feb-17 | Grant | 4,500 | -- | -- | 61% 7.38K to 11.88K | |
23-Feb-16 8:56 PM View: | Itt Inc. (ITT) | 19-Feb-16 | Grant | 2,765 | -- | -- | 60% 4.61K to 7.38K | |
27-Feb-15 9:24 PM View: | Itt Inc. (ITT) | 25-Feb-15 | Grant | 4,610 | -- | -- | 100% 0 to 4.61K |